Fig. 3: Immunogenicity in male and female mice with and without Montanide adjuvant. | npj Vaccines

Fig. 3: Immunogenicity in male and female mice with and without Montanide adjuvant.

From: Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice

Fig. 3

PfCSP ELISA titers in female BALB/cJ mice (a), male BALB/cJ mice (b), female C57Bl/6J mice (c), and male C57BL/6J mice (d) immunized as in Fig. 2 and assessed at the time of challenge (Day 70). Groups are as shown in the legend below each dataset; each data point is an individual mouse. NO ADJV indicates regimens where Montanide adjuvant was omitted at all priming and boosting steps. Error bars show mean and standard deviation. *p < 0.05; ns not significant p > 0.05 (ANOVA with post-hoc Tukey test for multiple comparisons).

Back to article page